Amarin’s Vascepa loses one more shield with Hikma’s generic approval esagonowsky Fri, 05/22/2020 – 11:04 More: Amarin's Vascepa loses one more shield with Hikma's generic approval Source: fierce
read moreNASH front-runner Intercept, already delayed twice, faces another FDA setback esagonowsky Fri, 05/22/2020 – 09:29 More: NASH front-runner Intercept, already delayed twice, faces another FDA setback Source: fierce
read moreFiercePharmaAsia—CanSino’s mRNA coronavirus vaccine; WuXi’s buildup; Fujifilm’s Avigan failure? aliu Fri, 05/22/2020 – 09:02 More: FiercePharmaAsia—CanSino's mRNA coronavirus vaccine; WuXi's buildup; Fujifilm's Avigan failure? Source: fierce
read more10 million tests have so far have been secured in a ‘landmark deal’ with industry, including Roche Diagnostics and Abbott Labs More: Gov't unveils coronavirus antibody testing scheme Source: News
read moreThe sites will be managed by the National Institute for Health Research (NIHR) and run by NHS trusts More: Gov't invests £7m in patient recruitment centres for clinical research Source: News
read moreSamsung will provide GSK with additional flexible capacity for large-scale biopharmaceutical product manufacturing More: GSK partners with Samsung to expand biopharma manufacturing Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals